1887

Abstract

SUMMARY

We evaluated the influence of host genetic factors on the course of murine cytomegalovirus (MCMV) lung infection after intranasal inoculation and on the development of interstitial pneumonitis after virus and cyclophosphamide (CP) administration. Susceptibility to virus replication in the lungs of various inbred murine strains was inherited as an autosomal dominant trait, which was associated with the H-2 locus. Similarly, the development of MCMV interstitial pneumonitis was inherited as an autosomal dominant, polygenic trait. Susceptibility to lung infection was necessary, but not sufficient for MCMV interstitial pneumonitis. Non-H-2-associated factors were also needed and probably related to CP metabolism or the character of immune recovery after CP administration. Therefore, inheritable host factors influence both susceptibility to MCMV lung infection and the genesis of MCMV interstitial pneumonitis.

Keyword(s): genetics , lung infection , MCMV and pneumonitis
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-65-12-2121
1984-12-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/65/12/JV0650122121.html?itemId=/content/journal/jgv/10.1099/0022-1317-65-12-2121&mimeType=html&fmt=ahah

References

  1. Bancroft G. J., Shellam G. R., Chalmer J. E. 1981; Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. Journal of Immunology 26:988–994
    [Google Scholar]
  2. Brock N., Gross R., Hohorst H. J., Klein H. O., Schneider B. 1971; Activation of cyclophosphamide in man and animals. Cancer 27:1512–1529
    [Google Scholar]
  3. Chalmer J. E., Mackenzie J. S., Stanley N. F. 1977; Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. Journal of General Virology 37:107–114
    [Google Scholar]
  4. Grundy (Chalmer) J. E., Melief C. J. M. 1982; Effect of Nu/Nu gene on genetically determined resistance to murine cytomegalovirus. Journal of General Virology 61:133–136
    [Google Scholar]
  5. Grundy (Chalmer) J. E., Mackenzie J. S., Stanley N. F. 1981; Influence of H-2 and non-H-2 genes in resistance to murine cytomegalovirus infection. Infection and Immunity 32:277–286
    [Google Scholar]
  6. Grundy (Chalmer) J. E., Trapman J., Allan J. E., Shellam G. R., Melief C. J. M. 1982; Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infection and Immunity 37:143–150
    [Google Scholar]
  7. Harnett G. B., Shellam G. R. 1982; Variation in murine cytomegalovirus replication in fibroblasts from different mouse strains in vitro: correlation with in vivo resistance. Journal of General Virology 62:39–47
    [Google Scholar]
  8. Hayes C. E., Klyczek K. K., Krum D. P., Whitecomb R. M., Hullett D. A., Canton H. 1984; Chromosome 4Jt gene controls murine T cell surface I-J expression. Science 223:559–563
    [Google Scholar]
  9. Henson D., Smith R. D., Gehrke J. 1961; Nonfatal mouse cytomegalovirus hepatitis. Combined morphologic, virologic and immunologic observations. American Journal of Pathology 49:871–880
    [Google Scholar]
  10. Ho M. 1982; Human cytomegalovirus infections in immunosuppressed patients. In Cytomegalovirus: Biology and Infection pp 171–204 By Ho M. New York & London: Plenum Press;
    [Google Scholar]
  11. Hurme M., Bang B. E., Sihvola M. 1980; Genetic differences in the cyclophosphamide induced immune suppression: weaker suppression of T-cell cytoxicity by cyclophosphamide activated by CBA mice. Clinical Immunology and Immunopathology 17:38–42
    [Google Scholar]
  12. Jordan M. C., Shanley J. D., Stevens J. G. 1977; Immunosuppression reactivates and disseminates latent murine cytomegalovirus infection. Journal of General Virology 37:419–423
    [Google Scholar]
  13. King R. C. 1962 Genetics Oxford & New York: Oxford University Press;
    [Google Scholar]
  14. Mannini A., Medearis D. N. 1961; Mouse salivary gland virus infection. American Journal of Hygiene 73:329–343
    [Google Scholar]
  15. Nedrud J. G., Collier A. M., Pagano J. S. 1979; Cellular basis for susceptibility to mouse cytomegalovirus: evidence from tracheal organ culture. Journal of General Virology 45:737–744
    [Google Scholar]
  16. Neiman P. E., Reeves W., Ray G., Flournoy N., Lerner K. G., Sale G. E., Thomas E. D. 1977; A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogenic bone marrow grafts. Journal of Infectious Diseases 136:754–767
    [Google Scholar]
  17. Peterson P. K., Balfour H. H., Marker S. C., Fryd D. S., Howard R. J., Simmons R. L. 1980; Cytomegalovirus disease in renal allograft recipients. A prospective study of the clinical features, risk factors, and impact on renal transplantation. Medicine 59:283–300
    [Google Scholar]
  18. Selgrade M. J. K., Osborn J. E. 1974; Role of macrophages in resistance to murine cytomegalovirus. Infection and Immunity 10:1308–1390
    [Google Scholar]
  19. Selgrade M. J. K., Collier A. M., Saxton L., Daniels M. J., Graham J. A. 1984; Comparison of the pathogenesis of murine cytomegalovirus in lung and liver following intraperitoneal and intratracheal infection. Journal of General Virology 65:515–523
    [Google Scholar]
  20. Shanley J. D., Jordan M. C., Cook M. L., Stevens J. G. 1979; Pathogenesis of reactivated latent murine cytomegalovirus infections. American Journal of Pathology 95:67–78
    [Google Scholar]
  21. Shanley J. D., Pesanti E. L., Nugent K. M. 1982; The pathogenesis of pneumonitis due to murine cytomegalovirus. Journal of Infectious Diseases 146:388–396
    [Google Scholar]
  22. Shellam G. R., Allan J. E., Papadimitriou J. M., Bancroft G. J. 1981; Increased susceptibility to cytomegalovirus infections in beige mutant mice. Proceedings of the National Academy of Sciences, U.S.A 78:5104–5108
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-65-12-2121
Loading
/content/journal/jgv/10.1099/0022-1317-65-12-2121
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error